The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Clinical trial NCT01081834 · COMPLETED

Trial details

NCT number: NCT01081834
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2010-03-01
Primary completion: 2011-08-01
Enrollment: 678

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.